The anticipated lifting of U.S. sanctions on Syria is poised to revitalize its war-torn economy, potentially attracting ...

Discover Q1 2025 earnings insights from Cellectar Biosciences (CLRB), focusing on regulatory progress for iopofosine I 131, strategic alternatives, ...

After billions of dollars in spending and decades of planning, NASA may be forced to abandon precious samples of air, rock ...